The Asia Pacific Thyroid Function Testing Market would witness market growth of 7.2% CAGR during the forecast period (2023-2031).
The China market dominated the Asia Pacific Thyroid Function Testing Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $531 million by 2031. The Japan market is registering a CAGR of 6.5% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 7.9% during (2024 - 2031).
Thyroid function testing has been widely adopted across various healthcare settings, driven by several factors that underscore its importance in clinical practice. For example, it has become a routine part of healthcare screenings and diagnostic protocols, especially in primary care settings. Healthcare providers frequently order thyroid function tests as part of comprehensive health assessments, annual check-ups, and evaluations for common symptoms associated with thyroid dysfunction.
The growing prevalence of thyroid disorders, coupled with increased awareness among healthcare professionals and the general population, has led to greater adoption of such testing. Rising incidence rates of conditions such as hypothyroidism, hyperthyroidism, thyroid nodules, and autoimmune thyroid diseases have emphasized the importance of early detection and monitoring through thyroid function tests.
With a rise in the prevalence of thyroid disorders, there is likely to be an increased demand for thyroid function tests (TFTs) in India. India, too, is no exception. According to a projection from various studies on thyroid disease, it has been estimated that about 42 million people in India suffer from thyroid disease. Hence, the increasing prevalence of thyroid-related disease and the growing elderly population in the region drive the market’s growth.
Free Valuable Insights: The Global Thyroid Function Testing Market is Predict to reach USD 7.5 Billion by 2031, at a CAGR of 6.4%
Based on End-use, the market is segmented into Hospitals, Diagnostic Laboratories, Clinics, and Research Laboratories & Institutes. Based on Test Type, the market is segmented into TSH Test, Free T4 Test, T4 Test, T3 Test, Free T3 Test, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
By End-use
By Test Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
